Komori
Piolax (5988) · InitiativeRestated

Identifying a Third Business Pillar Beyond Medical Devices

First written in FY2022. 3 of 4 entries say "Restated". Latest entry: FY2026.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022 – FY20262022: 120222023: 120232024: 120242025: 020252026: 12026
Same theme, other companies
Creating next-generation products and new businesses built on healthcare and automotiveA theme 3 companies write about · 0 as a headwind · 3 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Research and development is carried out by the development groups of the Optimal Development Promotion Department, MIRAI Development Department, Production Engineering Department and Product Development Department, including those at overseas sites, as well as the development division of the subsidiary 株式会社パイオラックス メディカル デバイス.」

    The Company continues its new business and development structure, including the MIRAI Development Department, but no specific results relating to the third core business are stated.
  2. FY2024RestatedAnnual report

    「At the same time, new trends in the automotive industry may make it difficult for the Group to expand profits simply by expanding its automotive business. Accordingly, the Company has begun efforts to create a new business that could become the third core business following medical devices.」

    The Company continues efforts to create a third core business following automotive and medical devices.
  3. FY2023RestatedAnnual report

    「To respond to the rapidly changing business environment, the Company is advancing new initiatives for sustainable growth of the Group, including opening a German representative office to expand its business in the European market, where CASE adoption is advancing, establishing the e Product Development Department to accelerate the expansion of orders for products addressing automotive electrification, and establishing the MIRAI Business Department to create a new business that could become the third core business following medical devices, without being constrained by its existing business areas.」

    The Company continues efforts through the MIRAI Business Department to identify a third core business following medical devices.
  4. FY2022First statedAnnual report

    「In April 2022, the Company established 2 new departments. One was the e Product Development Department, established to accelerate the expansion of orders for products addressing CASE, particularly electrification. The other was the MIRAI Business Department, established to identify a new business that could become the third core business following medical devices, without being constrained by its existing business areas.」

    The Company established the MIRAI Business Department in April 2022 to identify a third core business following automotive parts and medical devices.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Piolax yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.